Plotkin Financial Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Plotkin Financial Advisors's LLY Position: Q2 2026 in Review
Plotkin Financial Advisors increased its Eli Lilly (LLY) stake by 0.63% in Q2 2026, buying an estimated $6.13K and bringing the position to 964 shares worth $1.16M. The position accounts for 0.48% of the portfolio, ranked #40.
Plotkin Financial Advisors first reported a position in LLY in Q2 2020 and has held it in 24 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Plotkin Financial Advisors held 964 shares of Eli Lilly worth $1.16M as of Q2 2026.
- Plotkin Financial Advisors bought 6 Eli Lilly shares in Q2 2026, an estimated $6.13K.
- Eli Lilly made up 0.48% of Plotkin Financial Advisors's portfolio in Q2 2026, its #40 holding.
- Plotkin Financial Advisors first reported a position in Eli Lilly in Q2 2020 and has held it in 24 quarters since.
- 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Plotkin Financial Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.